Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | NAMPT | P43490 | 13/20 | 0.33 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30727613 | 0.88 | MAPT (0.38) | MAPTKDM4CNAMPT | |
| SCHEMBL30727603 | 0.80 | MAPT (0.36) | MAPTKDM4C | |
| SCHEMBL30727675 | 0.76 | MAPT (0.36) | MAPTKDM4CNAMPTENPP1 | |
| SCHEMBL30727607 | 0.76 | MAPT (0.34) | MAPTKDM4C | |
| SCHEMBL30727567 | 0.76 | NT5E (0.34) | MAPTKDM4CNAMPT | |
| SCHEMBL30727608 | 0.76 | MAPT (0.33) | MAPTKDM4C | |
| SCHEMBL30727629 | 0.74 | MAPT (0.34) | MAPTKDM4C | |
| SCHEMBL31399873 | 0.74 | MAPT (0.34) | MAPTKDM4CNAMPTENPP1 | |
| SCHEMBL30727587 | 0.74 | MAPT (0.34) | MAPTKDM4C | |
| SCHEMBL30727662 | 0.73 | ENPP1 (0.35) | MAPTKDM4CNAMPTENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4532495-A1 | CD73 INHIBITOR COMPOUNDS | Adorx therapeutics Limited (GB) | 2025-04-09 | — | — | EP | claimed |
| WO-2023233130-A1 | CD73 INHIBITOR COMPOUNDS | AdoRx Therapeutics Limited (GB) | 2023-12-07 | — | — | WO | claimed |
| EP-4532495-A1 | CD73 INHIBITOR COMPOUNDS | Adorx therapeutics Limited (GB) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023233130-A1 | CD73 INHIBITOR COMPOUNDS | AdoRx Therapeutics Limited (GB) | 2023-12-07 | — | — | WO | disclosed |